title: Current status of endoscopic therapy for ulcer bleeding.
abstract: This article provides an overview of the therapeutic endoscopic modalities available for the treatment of peptic ulcer bleeding. The benefits of endoscopic haemostasis have been fully demonstrated by three meta-analyses, which included most of the controlled trials published until 1992. In this review, an emphasis is placed on randomized, prospective comparative trials published during the past 20 years. Using an evidence-based medicine approach, the results of meta-analyses are translated into efficacy measures known as relative and absolute risk reductions, and number needed to treat. Single-modality treatments with injection agents such as epinephrine, sclerosants and thrombogenic substances, or with thermal therapies, are efficacious and comparable. Combination therapy involving injection and thermal techniques may offer an advantage over single-method therapy. The differences in the results between clinical trials and routine clinical practice, and among the various randomized studies, are probably related to operators' experience and variations in technique rather than to inconsistency of endoscopic haemostasis.
authors.affiliation: Hospital Privado, Catholic University School of Medicine, Cordoba, Cordoba, Argentina.
authors.forename: C
authors.initials: C
authors.lastname: Rollhauser
authors.forename: D E
authors.initials: DE
authors.lastname: Fleischer
mesh_terms: D000208:Acute Disease; D000818:Animals; D004381:Duodenal Ulcer / Q000150:complications*; D016558:Hemostasis, Endoscopic / Q000379:methods*; D006490:Hemostatics / Q000008:administration & dosage; D006801:Humans; D007267:Injections; D015201:Meta-Analysis as Topic; D010438:Peptic Ulcer Hemorrhage / Q000209:etiology / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D013276:Stomach Ulcer / Q000150:complications*
chemical_list: D006490:Hemostatics